Skip to main content

Table 5 Baseline characteristics prior to hospitalization for 49 patients (with CR-AB and/or CR-PA) and 438 controls (without CR-AB and CR-PA)

From: A prospective surveillance study for multidrug-resistant bacteria colonization in hospitalized patients at a Thai University Hospital

Baseline characteristics CR-AB and/or
CR-PA (n = 49)
No CR-AB and CR-PA (n = 438) p-value
Mean age ± SD (years) 66.7 ± 18 61.1 ± 17.8 0.04
Male gender 18 (36.7%) 203 (46.4%) 0.20
Previous hospitalization 32 (65.3%) 179 (40.9%) 0.001
Transfer status
From other hospital 13 (26.5%) 43 (9.8%) 0.001
From a long-term care facility 4 (8.2%) 2 (0.5%) < 0.001
Underlying diseases
Any underlying disease 48 (98.0%) 372 (84.9%) 0.01
Hypertension 33 (67.4%) 257 (58.7%) 0.24
Diabetes mellitus 20 (40.8%) 164 (37.4%) 0.64
Cardiovascular disease 16 (32.7%) 117 (26.7%) 0.38
Cerebrovascular disease 23 (46.9%) 74 (16.9%) < 0.001
Chronic liver disease 9 (18.4%) 79 (18.0%) 0.95
Chronic renal disease 8 (16.3%) 56 (12.8%) 0.49
Chronic lung disease 7 (14.3%) 56 (12.8%) 0.77
Malignancy 7 (14.3%) 80 (18.3%) 0.49
Solid malignancy 7 (14.3%) 68 (15.5%) 0.82
Hematologic malignancy 0 12 (2.7%) 0.24
Hematologic diseases 6 (12.2%) 41 (9.4%) 0.52
Prior organ transplantation 1 (2.0%) 6 (1.4%) 0.71
Receipt of any immunosuppressive agent 6 (12.2%) - 53 (12.1%) 0.98
HIV infection 1 (2.0%) 15 (3.4%) 0.61
Previous antibiotic exposure within 90 days after hospitalization
 Any antibiotic 26 (53.1%) 122 (27.9%) < 0.001
 Penicillins 1 (2.0%) 18 (4.1%) 0.48
 Cephalosporins 10 (20.4%) 50 (11.4%) 0.07
 Carbapenems 9 (18.4%) 24 (5.5%) 0.001
 Beta-lactam/beta-lactamase inhibitors 7 (14.3%) 20 (4.6%) 0.005
 Fluoroquinolones 8 (16.3%) 38 (8.7%) 0.08
 Macrolides 4 (8.2%) 15 (3.4%) 0.10
 Others 8 (16.3%) 34 (7.8%) 0.04
Previous use of indwelling catheters
 Urinary catheter 19 (38.8%) 54 (12.3%) < 0.001
 Nasogastric tube 16 (32.7%) 29 (6.6%) < 0.001